Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 · Journal of Clinical Oncology · 4,815 citations
https://doi.org/10.1200/jco.2008.18.1370
T
Torsten O. Nielsen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
485
Papers
54.4K
Citations
105
h-index
238
i10-index
Torsten O. Nielsen is an academic researcher from University of British Columbia Hospital. The author has contributed to research in topics: Breast Cancer Treatment Studies & Sarcoma Diagnosis and Treatment & HER2/EGFR in Cancer Research. The author has an h-index of 105, co-authored 413 publications.
ORCID: 0000-0003-3769-2517Papers by this author
worksImmunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
2004 · Clinical Cancer Research · 2,642 citations
https://doi.org/10.1158/1078-0432.ccr-04-0220
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 · JNCI Journal of the National Cancer Institute · 2,199 citations
https://doi.org/10.1093/jnci/djp082
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
2011 · JNCI Journal of the National Cancer Institute · 1,963 citations
https://doi.org/10.1093/jnci/djr393
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
2015 · BMC Medical Genomics · 547 citations
https://doi.org/10.1186/s12920-015-0129-6
CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
2012 · Breast Cancer Research · 432 citations
https://doi.org/10.1186/bcr3148
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat